Think about the ONE TO THREE jump. I think that is most likely....FDA declares Phase II unnessary

CTIX to start Phase III trial......is the headline........CLSN did it because they were ALONE in the field bring new help to HCC patients........the MAGNITUDE of the possible patient population to be served here would be the justification